The Impact of Prolonged Chemotherapy to Surgery Interval and Neoadjuvant Radiotherapy on Pathological Complete Response and Overall Survival in Pancreatic Cancer Patients

Basem Azab, Francisco Igor Macedo, David Chang, Caroline Ripat, Dido Franceschi, Alan S Livingstone, Danny Yakoub

Open source

DOI
10.1177/1179554920919402
Published
2020-01
Container
Clinical Medicine Insights: Oncology
Publisher
SAGE Publications
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1177/1179554920919402,
  title = {The Impact of Prolonged Chemotherapy to Surgery Interval and Neoadjuvant Radiotherapy on Pathological Complete Response and Overall Survival in Pancreatic Cancer Patients},
  author = {Basem Azab and Francisco Igor Macedo and David Chang and Caroline Ripat and Dido Franceschi and Alan S Livingstone and Danny Yakoub},
  year = {2020},
  journal = {Clinical Medicine Insights: Oncology},
  doi = {10.1177/1179554920919402},
  url = {https://doi.org/10.1177/1179554920919402}
}

RIS

TY  - JOUR
TI  - The Impact of Prolonged Chemotherapy to Surgery Interval and Neoadjuvant Radiotherapy on Pathological Complete Response and Overall Survival in Pancreatic Cancer Patients
AU  - Basem Azab
AU  - Francisco Igor Macedo
AU  - David Chang
AU  - Caroline Ripat
AU  - Dido Franceschi
AU  - Alan S Livingstone
AU  - Danny Yakoub
PY  - 2020
JO  - Clinical Medicine Insights: Oncology
DO  - 10.1177/1179554920919402
UR  - https://doi.org/10.1177/1179554920919402
ER  - 

APA

Azab, B., Macedo, F. I., Chang, D., Ripat, C., Franceschi, D., Livingstone, A. S., & Yakoub, D. (2020). The Impact of Prolonged Chemotherapy to Surgery Interval and Neoadjuvant Radiotherapy on Pathological Complete Response and Overall Survival in Pancreatic Cancer Patients. Clinical Medicine Insights: Oncology. https://doi.org/10.1177/1179554920919402

Source records